191 related articles for article (PubMed ID: 33525876)
1. A CRISPR-Cas9-Based Near-Infrared Upconversion-Activated DNA Methylation Editing System.
Chi J; Zhao J; Wei S; Li Y; Zhi J; Wang H; Hou X; Hu L; Zheng X; Gao M
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6043-6052. PubMed ID: 33525876
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared upconversion-activated CRISPR-Cas9 system: A remote-controlled gene editing platform.
Pan Y; Yang J; Luan X; Liu X; Li X; Yang J; Huang T; Sun L; Wang Y; Lin Y; Song Y
Sci Adv; 2019 Apr; 5(4):eaav7199. PubMed ID: 30949579
[TBL] [Abstract][Full Text] [Related]
3. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
4. A Rationally Designed Semiconducting Polymer Brush for NIR-II Imaging-Guided Light-Triggered Remote Control of CRISPR/Cas9 Genome Editing.
Li L; Yang Z; Zhu S; He L; Fan W; Tang W; Zou J; Shen Z; Zhang M; Tang L; Dai Y; Niu G; Hu S; Chen X
Adv Mater; 2019 May; 31(21):e1901187. PubMed ID: 30957918
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
Chen X; Chen Y; Xin H; Wan T; Ping Y
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
8. Photoactivatable RNA N
Zhao J; Li B; Ma J; Jin W; Ma X
Small; 2020 Jul; 16(30):e1907301. PubMed ID: 32583968
[TBL] [Abstract][Full Text] [Related]
9. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
10. Editing DNA Methylation in the Mammalian Genome.
Liu XS; Wu H; Ji X; Stelzer Y; Wu X; Czauderna S; Shu J; Dadon D; Young RA; Jaenisch R
Cell; 2016 Sep; 167(1):233-247.e17. PubMed ID: 27662091
[TBL] [Abstract][Full Text] [Related]
11. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
[TBL] [Abstract][Full Text] [Related]
12. Transgenerationally Transmitted DNA Demethylation of a Spontaneous Epialleles Using CRISPR/dCas9-TET1cd Targeted Epigenetic Editing in Arabidopsis.
Wang M; He L; Chen B; Wang Y; Wang L; Zhou W; Zhang T; Cao L; Zhang P; Xie L; Zhang Q
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142407
[TBL] [Abstract][Full Text] [Related]
13. Programmable targeted epigenetic editing using CRISPR system in Bombyx mori.
Liu Y; Ma S; Chang J; Zhang T; Chen X; Liang Y; Xia Q
Insect Biochem Mol Biol; 2019 Jul; 110():105-111. PubMed ID: 31022512
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
15. Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment.
Kim SM; Shin SC; Kim EE; Kim SH; Park K; Oh SJ; Jang M
ACS Nano; 2018 Aug; 12(8):7750-7760. PubMed ID: 30028587
[TBL] [Abstract][Full Text] [Related]
16. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
Lombardi L; Turner SA; Zhao F; Butler G
Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
[TBL] [Abstract][Full Text] [Related]
17. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
Ebrahimi V; Hashemi A
Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
[TBL] [Abstract][Full Text] [Related]
18. Harnessing targeted DNA methylation and demethylation using dCas9.
Pflueger C; Swain T; Lister R
Essays Biochem; 2019 Dec; 63(6):813-825. PubMed ID: 31724704
[TBL] [Abstract][Full Text] [Related]
19. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
20. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
